Definition
Sleep medications are a diverse category with distinct mechanisms, risks, and clinical roles. They are neither universally helpful nor universally harmful.
Why it matters
Simplistic framing — all sleep meds are bad, or all are fine — harms patients. Precision matters.
The Science
Benzodiazepines and Z-drugs promote sleep but reduce sleep quality, produce tolerance, and carry dependence and cognitive risks with chronic use. Sedating antihistamines have next-day cognitive costs. Newer agents (orexin receptor antagonists) have different profiles. CBT-I outperforms medications in long-term outcomes for chronic insomnia.
The NSI Perspective
NSI holds medication as a real tool with real costs. Use it with clarity about tradeoffs and with a plan.
Clinical Implications
Short courses for acute insomnia can be appropriate. Long-term chronic use warrants review and CBT-I referral.
Practical Application
If a sleep medication has been part of your life for years, this is worth reviewing — not to shame you, but because better options may exist.
References
- 1.Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133.